Wednesday, August 17, 2022 3:17:51 PM
Then the hard fact is that people will view Regen as a hit and run kind of stock, simple because things go so slow & that most of the Pharmaceutical Co's don't make it past the first stage in the Clinical trials? Some have good products but don't have the money to go through the full Clinical Trial phase, though the NR2F6 Chemistry is unlike the more invasive chemistries that require more time and money!
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM